JESSICA TREISE: Open Payments
NPI 1437892072 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 39 payments from 13 companies in 2025. Trend: 2023 $1,010 · 2024 $910 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $141 |
| Exact Sciences Corporation | 4 | $114 |
| Novo Nordisk Inc | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Amgen Inc. | 4 | $74 |
| ABBVIE INC. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| PFIZER INC. | 2 | $32 |
| Eisai Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, CAPLYTA, EVENITY, VRAYLAR, Wegovy, BREZTRI, Ozempic.
Industry payments across FL — which companies pay providers there.
